A Peek Into The Market Before The Trading Starts

Symbols: AES, BMY, K, PEP, VRUS, WIN
Share

Pre-open movers US stock futures are slightly lower this morning, ahead of October non-farm payrolls data. Futures for the Dow Jones Industrial Average dropped 5 points to 11,971.00 and S&P 500 index futures fell 1.40 points to 1,254.30. Nasdaq 100 futures declined 2.50 points to 2,358.50.

A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index rose 0.47%, London's FTSE 100 Index moved up 0.66%, French CAC 40 index rose 0.34% and German DAX 30 index gained 0.04%.

Asian markets ended higher, with Japan's Nikkei Stock Average rising 1.8389%, Australia's S&P/ASX 200 moving up 2.48% and China's Shanghai Composite rising 0.81%. Hong Kong's Hang Seng Index surged 3.1196% and India's Sensex gained 0.46%.

Broker Recommendation Analysts at Jefferies & Company upgraded Kellogg Company (NYSE: K) from “underperform” to “hold.”

Kellogg shares gained 0.18% to $50.00 in after-hours trading.

Breaking news

  • AES Corp (NYSE: AES) reported a rise in its third-quarter profit. To read the full news, click here.
  • Pharmasset Inc (NASDAQ: VRUS) and Bristol-Myers Squibb Company (NYSE: BMY) announced today the addition of four treatment arms to the ongoing Phase IIa trial evaluating the combination of Pharmasset's PSI-7977, a nucleotide polymerase inhibitor, and Bristol-Myers Squibb Company's daclatasvir, an investigational NS5A replication complex inhibitor, for the treatment of chronic hepatitis C. To read the full news, click here.
  • Windstream Inc (NASDAQ: WIN) reported a 16% drop in its third-quarter profit. To read the full news, click here.
  • Tingyi Holding Corp and PepsiCo Inc (NYSE: PEP) today announced they have entered into an agreement to form a strategic alliance in China. To read the full news, click here.

 
 
< Previous
The Benchmark Company Raised EPS Estimates on Belo
Next >
The Benchmark Company Maintains Buy Rating and $7 PT on Columbia Laboratories
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust